UNITY Biotechnology, Inc. Reports Third Quarter 2023 Financial Results and Business Updates
SOUTH SAN FRANCISCO, Calif., Nov. 13, 2023 (GLOBE NEWSWIRE) — UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today reported financial results for the third quarter ended September 30, 2023.
Related news for (UBX)
- MoBot alert highlights: NASDAQ: CTXR, NASDAQ: PTNM, NASDAQ: BSGM, NASDAQ: VERO, NASDAQ: UBX (07/01/25 04:00 PM)
- CubicFarm Systems Corp. Provides Default Status Report
- CubicFarm Systems Corp. Provides Default Status Report
- UNITY Biotechnology Announces Complete 36-Week Results from the ASPIRE Phase 2b Study of UBX1325 in Diabetic Macular Edema and Provides Corporate Updates
- UNITY Biotechnology to Present at the ARVO 2025 Annual Meeting